|
Press Releases |
|
|
|
Thursday, June 2, 2022 |
|
Connected Transactions Involving Subscription by Vivo Suzhou Fund and Centerlab for TOT BIOPHARM Shares |
On June 1, 2022, TOT BIOPHARM (Stock code: 1875. HK) announced that the company entered into a Share Subscription Agreement with VIVO Suzhou Fund and Centerlab. Pursuant to the agreement, Vivo Suzhou Fund and Centerlab agreed to subscribe for 116,250,000 and 33,750,000 shares of TOT BIOPHARM more info >> |
|
Wednesday, June 1, 2022 |
|
维梧苏州基金及晟德大药厂认购东曜药业股份 |
东曜药业(股票代码:1875.HK)宣布公司与维梧苏州基金及晟德大药厂订立股份认购协议。根据协议,维梧苏州基金与晟德大药厂将分别认购东曜药业配售股份116,250,000股及33,750,000股,认购价每股 3.15港元(依据过往5个交易日溢价发行),合共150,000,000股,占本公告日期公司已发行股本约24.38%。 more info >> |
|
維梧蘇州基金及晟德大藥廠認購東曜藥業股份 |
東曜藥業(股票代碼:1875.HK)宣佈公司與維梧蘇州基金及晟德大藥廠訂立股份認購協議。根據協議,維梧蘇州基金與晟德大藥廠將分別認購東曜藥業配售股份116,250,000股及33,750,000股,認購價每股 3.15港元(依據過往5個交易日溢價發行),合共150,000,000股,占本公告日期公司已發行股本約24.38%。 more info >> |
|
Connected Transactions Involving Subscription by Vivo Suzhou Fund and Centerlab for TOT BIOPHARM Shares |
TOT BIOPHARM (Stock code: 1875. HK) announced that the company entered into a Share Subscription Agreement with VIVO Suzhou Fund and Centerlab. Pursuant to the agreement, Vivo Suzhou Fund and Centerlab agreed to subscribe for 116,250,000 and 33,750,000 shares of TOT BIOPHARM more info >> |
|
Friday, August 13, 2021 |
|
東曜藥業2021年中期營業收入大幅增長78%至人民幣2,313萬元 |
東曜藥業股份有限公司(「東曜藥業」或「公司」;股票代碼:1875.HK)- 專注於創新型腫瘤藥物及療法開發和商業化的生物製藥公司,今天欣然宣佈其截至2021年6月30日止6個月未經審核中期業績。 more info >> |
|
TOT BIOPHARM 2021 Interim Revenue Surges 78% to RMB23.13 million |
TOT BIOPHARM International Company Limited ("TOT BIOPHARM" or the "Group"; stock code: 1875.HK), a biopharmaceutical company dedicated to developing and commercializing innovative oncology drugs and therapies, announced today its unaudited interim results for the six months ended 30 June 2021. more info >> |
|
Wednesday, March 24, 2021 |
|
東曜藥業宣佈2020年多項重點抗腫瘤藥物進入關鍵臨床階段 |
東曜藥業股份有限公司(「東曜藥業」或「公司」;股票代碼:1875.HK)- 專注於創新型腫瘤藥物及療法的臨床階段生物製藥公司,今天欣然宣佈其截至2020年12月31日止年度(「年內」)之經審核全年業績。 more info >> |
|
TOT BIOPHARM Announces A Number of Key Anti-Tumor Drugs Have Entered the Pivotal Clinical Stage in 2020 |
TOT BIOPHARM International Company Limited ("TOT BIOPHARM" or the "Company"; stock code: 1875.HK), a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative oncology drugs and therapies, announced today its audited annual results for the year ended 31 December 2020. more info >> |
|
Friday, October 16, 2020 |
|
东曜药业股份有限公司完善公司管理架构 推动战略发展升级 |
东曜药业股份有限公司(「东曜药业」或「公司」;股票代码:1875.HK)今日欣然宣布委任执行董事黄纯莹女士(「黄女士」)为董事会副主席,辞任总经理一职;同时宣布委任执行董事兼首席科学官刘军博士(「刘博士」)为公司首席执行官,并不再兼任首席运营官及副总经理职务。 more info >> |
|
東曜藥業股份有限公司完善公司管理架構 推動戰略發展升級 |
東曜藥業股份有限公司(「東曜藥業」或「公司」;股票代碼:1875.HK)今日欣然宣佈委任執行董事黃純瑩女士(「黃女士」)為董事會副主席,辭任總經理一職;同時宣佈委任執行董事兼首席科學官劉軍博士(「劉博士」)為公司首席執行官,並不再兼任首席運營官及副總經理職務。 more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
New XSeed Labs Research Team Starts Activity in the U.S. in Collaboration With Boehringer Ingelheim
May 16, 2024 22:00 HKT/SGT
|
|
|
加速大灣區互聯互通,內地乘客可在曹操出行下單大巴直達港澳
May 16, 2024 21:52 HKT/SGT
|
|
|
DEXIS Innovation Continues With New DEXIS Ti2 Sensor as Successor to the DEXIS Titanium Sensor, the #1 Selling Intraoral Sensor in the United States
May 16, 2024 21:30 HKT/SGT
|
|
|
Horus: Million Dollar Air-Mail NFT Drop on Base
May 16, 2024 21:11: JST
|
|
|
Horus: Million Dollar Air-Mail NFT Drop on Base
May 16, 2024 20:11 HKT/SGT
|
|
|
香港贸发局第三届「国际医疗健康周」正式展开
May 16, 2024 18:24 HKT/SGT
|
|
|
香港貿發局第三屆「國際醫療健康周」正式展開
May 16, 2024 18:15 HKT/SGT
|
|
|
HKTDC kicks off third International Healthcare Week
May 16, 2024 18:00 HKT/SGT
|
|
|
CleverTap's 2024 Market Research Report Unveils that Brands Implementing Higher AI Adoption See 4x Boost in Conversions
May 16, 2024 17:00 HKT/SGT
|
|
|
Sri Trang (SET: STA) announces delivery of EUDR rubber to customers
May 16, 2024 17:00 HKT/SGT
|
|
|
Q2 Metals Announces Re-Assay Results and Spring 2024 Exploration Plan for Cisco Lithium Property, James Bay Territory, Quebec, Canada
May 16, 2024 15:09 HKT/SGT
|
|
|
World CX Summit 2024: Steering the future of customer experience forward
May 16, 2024 15:05 HKT/SGT
|
|
|
Rover Announces and Closes $0.03 Unit Financing
May 16, 2024 05:00 HKT/SGT
|
|
|
New Research Increases Confidence in the Benefits of Vegan Diets for Dogs
May 16, 2024 05:00 HKT/SGT
|
|
|
3rd Annual Clean Power & New Energy 2024
May 15, 2024 21:53 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|